Ars TechnicaAfter ruining 75M J&J doses, Emergent gets FDA clearance for 25M dosesJun 16, 2021more_vert
ReutersU.S. authorizes another 14 mln doses of Johnson & Johnson's COVID-19 vaccine -sourcesJun 15, 2021Michael ErmanBy Michael Ermanmore_vert
The New York TimesHow Emergent BioSolutions Earned Profits But Delivered Disappointing Vaccine ReturnsJul 29, 2021Sharon LaFraniere, Chris Hamby & Rebecca RuizBy Sharon LaFraniere, Chris Hamby & Rebecca Ruizmore_vert